SUNHAWK BIO

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

N/A

Website

sunhawkvision.com

Country

Taiwan

Exchange

Taipei Exchange

Founded 2019

Sunhawk Vision Biotech, Inc., a drug development company provides the research and development of children's myopia eye drops, dry eye drops, and other nucleic acid new drugs for the treatment of ocular surface diseases in Taiwan.

The company develops SHJ002 eye drops, which have completed a Phase 2 clinical trial for the treatment of dry eye disease in adult patients and corneal erosion in patients with Sjogren's syndrome In a Phase 2 clinical trial for myopia control in young children. Founded in 2019, Sunhawk Vision Biotech is based in Taipei, Taiwan.

Key Stats

52-Week Range

NT$26.90NT$83.60

BetaN/A

Trailing P/EN/A

Forward P/EN/A

Trailing EPS-2.47

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.